Mast cells in melanocytic tumours
暂无分享,去创建一个
[1] S. Galli. New concepts about the mast cell , 1994 .
[2] D. Schadendorf,et al. Human mast cells produce IL-8. , 1993, Journal of immunology.
[3] D. Schadendorf,et al. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. , 1993, Journal of immunology.
[4] D. Rubinstein,et al. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines. , 1993, Cancer research.
[5] Y. Tomita,et al. Histologic grading in soft‐tissue sarcomas. An analysis of 194 cases including agnor count and mast‐cell count , 1993, International journal of cancer.
[6] R. Kerbel,et al. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression [published erratum appears in J Cell Biol 1993 Apr;121(2):following 477] , 1993, The Journal of cell biology.
[7] D. Schadendorf,et al. Responsiveness to interferon treatment of human melanoma cells correlates to immunophenotype. , 1993, Melanoma research.
[8] D. Woolley,et al. Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NF. , 1991, British Journal of Cancer.
[9] D. Morton,et al. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor. , 1991, Cancer research.
[10] V. Swope,et al. Interleukins 1α and 6 and tumor necrosis factor-α are paracrine inhibitors of human melanocyte proliferation and melanogenesis , 1991 .
[11] I. Verlaan,et al. Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors , 1990, The Journal of cell biology.
[12] A. Halpern,et al. Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.
[13] R. Murphy,et al. Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes. , 1989, The Journal of investigative dermatology.
[14] H. Rockette,et al. Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). , 1989, Human pathology.
[15] K. Aozasa,et al. Prognostic significance of mast cells in soft tissue sarcoma , 1988, Cancer.
[16] J. Starkey,et al. Mast‐cell‐deficient W/Wv mice exhibit A decreased rate of tumor angiogenesis , 1988, International journal of cancer.
[17] E. Bröcker,et al. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression , 1988, International journal of cancer.
[18] D. Woolley,et al. Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma. , 1986, British Journal of Cancer.
[19] D. Woolley,et al. Host-mediated effectors of tumor invasion: role of mast cells in matrix degradation , 1986, Clinical & Experimental Metastasis.
[20] W. Roche. The nature and significance of tumour‐associated mast cells , 1986, The Journal of pathology.
[21] G. Scapigliati,et al. In vitro generated mast cells express natural cytotoxicity against tumour cells. , 1985, Immunology.
[22] Roche Wr. Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. , 1985 .
[23] P. Askenase,et al. The effect of histamine, antihistamines, and a mast cell stabilizer on the growth of cloudman melanoma cells in DBA/2 mice. , 1983, The Journal of investigative dermatology.
[24] M. Mihm,et al. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. , 1982, Journal of immunology.
[25] F. Hartveit. Mast cells and metachromasia in human breast cancer: Their occurrence, significance and consequence: A preliminary report , 1981, The Journal of pathology.
[26] D. Schadendorf,et al. Determination of granulocyte/macrophage-colony-stimulating factor secretion by human melanoma cells and its effects on human melanoma cell proliferation , 2005, Journal of Cancer Research and Clinical Oncology.
[27] E. Bröcker,et al. Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype , 2004, Cancer Immunology, Immunotherapy.
[28] H. Tritsch. Untersuchungen über Relationen zwischen entzündlicher Infiltration, Zelltyp und Prognose beim malignen Melanom , 2004, Archiv für dermatologische Forschung.
[29] D. Katenkamp,et al. Untersuchungen zur prognostischen Bedeutung von Entzündungszellen in malignen Weichgewebstumoren des Menschen. Zugleich ein Beitrag zur Malignitätsgraduierung , 1992 .
[30] V. Swope,et al. Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. , 1991, The Journal of investigative dermatology.
[31] S. Galli,et al. Mast cells as a source of multifunctional cytokines. , 1990, Immunology today.
[32] C. Garbe,et al. Cytostatic and cytotoxic effects of recombinant tumor necrosis factor-α on sensitive human melanoma cells in vitro may result in selection of cells in vitro may results in selection of cells with enhanced markers of malignancy , 1990 .
[33] T. Maciag,et al. The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.
[34] Y. Kitamura,et al. Heterogeneity of mast cells and phenotypic change between subpopulations. , 1989, Annual review of immunology.
[35] J. Folkman,et al. Angiogenic factors. , 1987, Science.
[36] W. Roche. Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. , 1985, The American journal of pathology.
[37] L. de Leij,et al. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin. , 1983, Clinical and experimental immunology.
[38] S. Poppema,et al. Insitu analysis of the mononuclear cell infiltrate in primary malignant-melanoma of the skin , 1983 .
[39] C. Hoch‐Ligeti,et al. Association of tissue mast cells and skin tumors. , 1961, Archives of dermatology.
[40] M. B. Sulzberger,et al. Chloroquine for Chronic Discoid Lupus Erythematosus: Intralesional Injections , 1961 .